logo

For the Inventor, By the Inventor

Munich, Germany

Klinge Pharma Gmbh


USPTO Granted Patents = 23

% Expired Patents = 4.3


Trademarks = 4

Forward Citations = 459

Loading Chart...
Loading Chart...

50 inventors (with patents filed for the assignee):

goldMedal Friedemann Reiter (10 out of 14 patents)

silverMedal Klaus Seibel (9 out of 13 patents)

bronzeMedal Benno Rattel (5 out of 15 patents)

4.  Elfi Biedermann (5 out of 9 patents)

5.  Max Hasmann (5 out of 9 patents)

6.  Barbara Schein (5 out of 9 patents)

7.  Klaus Vogt (5 out of 9 patents)

8.  Helmut Grill (5 out of 10 patents)

9.  Roland Löser (4 out of 4 patents)

10.  Fritz Stanislaus (4 out of 5 patents)

11.  Roland Loser (4 out of 8 patents)

12.  Michael Schliack (4 out of 6 patents)

13.  Katja Wosikowski (3 out of 6 patents)

14.  Isabel Schemainda (3 out of 5 patents)

15.  Gerhard Schneider (3 out of 3 patents)


23 patents:

1. 6903118 - Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides (2005-06-07),
2. 6593344 - Piperadinyl-substituted pyridylalkane, alkene and alkine carboxamides (2003-07-15),
3. 6506572 - Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy (2003-01-14),
4. 6451816 - Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression (2002-09-17),
5. 6444823 - Pyridyl alkane acid amides as cytostatics and immunosuppressives (2002-09-03),
6. 6419959 - Galenic composition containing opioid antagonists (2002-07-16),
7. 6077534 - Production of pharmaceutical formulations for treatment of edema and (2000-06-20),
8. 5693863 - Method for the production of E-1-�4'- (2- Dimethylaminoethoxy) - (1997-12-02),
9. 5493051 - Lifibrol and its use (1996-02-20),
10. 5391375 - Transdermal therapeutical system with physostigmine as active component (1995-02-21),
11. 5266721 - Process for preparing the pure enantiomers of lifibrol and its alkyl (1993-11-30),
12. 5254594 - Remedies for bone diseases (1993-10-19),
13. 5153353 - p-Oxybenzoic acid derivatives, process for the preparation thereof and (1992-10-06),
14. 5149865 - New p-oxibenzoic acid derivatives, process for their preparation and (1992-09-22),
15. 5089267 - Transdermal therapeutical system comprising physostigmine as active (1992-02-18),
Klinge Pharma GmbH is a pharmaceutical company based in Germany. They specialize in the development, manufacturing, and distribution of high-quality, innovative pharmaceutical products. With a focus on research and development, Klinge Pharma is committed to improving the health and well-being of patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

23 Patents

#117 in W-8000 Munich

#1,972 in Germany

#27,577 in the World

Munich, DE
Munich, Germany

Klinge Pharma Gmbh

Forward Citations = 459

50 inventors:

goldMedal Friedemann Reiter (10 out of 14 patents)

silverMedal Klaus Seibel (9 out of 13 patents)

bronzeMedal Benno Rattel (5 out of 15 patents)

4.  Elfi Biedermann (5 out of 9 patents)

5.  Max Hasmann (5 out of 9 patents)

Please report any incorrect information to [email protected]
Loading…